| HOME >> BIOLOGY >> TECHNOLOGY |
Ambion's newest line of plasmid siRNA
expression vectors, pSilencer 4.1-CMV,
feature polymerase (pol) II promoters that drive transcription
of both an siRNA template and an antibiotic resistance gene.
The CMV promoter is used to drive siRNA expression. This
strong promoter is active in a broad range of cell types and
performs better than most pol III promoters under long term
selection.
One use of plasmid-based siRNA
expression vectors is for long term gene silencing studies in
mammalian cells. Typically these vectors encode a hairpin
siRNA under the control of a polymerase III promoter and an
antibiotic resistance gene driven by a polymerase II promoter.
While it is possible to use such vectors to produce stable
cell lines expressing siRNAs that silence their targets, there
are, to date, very few published accounts of doing so (Xia
2002). One explanation for the difficulty in producing such
clones is possible interference between the pol II and III
promoters. Although the exact mechanism is not understood, it
is hypothesized that when pol II and III promoters are in
close proximity, interference of transcription between the two
promoters can occur. This suggests that clones derived from a
transfection/selection experiment will either express the
siRNA or the antibiotic resistance gene but rarely express
both. To overcome this potential problem, we have constructed
three '"/>
Source: